Diffusion Pharmaceuticals Announces Validation of European Patent for Oral Formulations of TSC Pharmaceutical Investing
Xanthic Partners With ABH Pharma Inc. To Produce CBD-Infused Dietary Supplements For National U.S. Retailers And E-Commerce Customers Biotech Investing
Alnylam Reports Updated Positive Results from Phase 1/2 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 (PH1) Life Science Investing
Takeda Announces Term Loan Credit Agreement and Amendment to Bridge Credit Agreement in Connection with Proposed Shire Acquisition Pharmaceutical Investing
Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease Biotech Investing
Fortive Announces Binding Offer to Acquire the Advanced Sterilization Products Business from Johnson & Johnson Pharmaceutical Investing
